Sustained Downregulation of Cortical Adrenergic Receptor Density with Maintenance Electroconvulsive Stimulation

Andrew Francis1, Laura Fochtmann

  • 1Department of Psychiatry and Behavioral Sciences, State University of New York, Stony Brook, New York, USA.

Convulsive Therapy
|January 1, 1993
PubMed

Insights

Electroconvulsive stimulation (ECS) downregulates beta-adrenergic receptors. Maintenance ECS, given twice weekly, sustained this downregulation for two months in rats, unlike the natural recovery seen without it.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Central beta-adrenergic receptor downregulation is a known effect of electroconvulsive stimulation (ECS) and antidepressants.
  • Beta-receptors are crucial in models of affective disorders and their treatment.

Purpose of the Study:

  • To investigate if the downregulation of rat cortical beta-receptor density induced by an initial ECS course is maintained with long-term maintenance ECS.
  • To determine the efficacy of maintenance ECS in sustaining neurochemical changes associated with antidepressant effects.

Main Methods:

  • Rats received an initial series of 10 daily ECS treatments.
  • One group received no further ECS, allowing for natural receptor recovery observation.
  • A second group received maintenance ECS twice weekly for 2 months post-initial series.
  • Cortical beta-receptor density was measured to assess downregulation.

Main Results:

  • The initial 10-day ECS course decreased beta-receptor density, which returned to baseline 16 days after the last ECS in the absence of maintenance.
  • In contrast, maintenance ECS administered twice weekly for 2 months successfully sustained the beta-receptor downregulation.
  • This indicates that a bimonthly maintenance schedule is sufficient to maintain ECS-induced receptor changes.

Conclusions:

  • Maintenance electroconvulsive stimulation can sustain the downregulation of central beta-adrenergic receptors.
  • These findings have implications for understanding the neurochemical mechanisms of ECS and optimizing maintenance treatment strategies for affective disorders.

Related Concept Videos

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...